C-CAR168 CAR T Cell Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for C-CAR168 CAR T Cell Therapy, covering 2026-02-03 to 2026-02-03. Get the full timeline:
Most recent: Clinical Trial Update: C-CAR168 CAR T Cell Therapy for Refractory Autoimmune Disease [Phase 1, Phase 2]